Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Operating Margin (2016 - 2025)

Historic Operating Margin for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 6.59%.

  • Nephros' Operating Margin rose 7400.0% to 6.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.06%, marking a year-over-year increase of 151500.0%. This contributed to the annual value of 0.04% for FY2024, which is 112300.0% up from last year.
  • Nephros' Operating Margin amounted to 6.59% in Q3 2025, which was up 7400.0% from 5.61% recorded in Q2 2025.
  • In the past 5 years, Nephros' Operating Margin ranged from a high of 11.61% in Q1 2025 and a low of 71.65% during Q1 2022
  • Moreover, its 5-year median value for Operating Margin was 12.27% (2023), whereas its average is 18.32%.
  • As far as peak fluctuations go, Nephros' Operating Margin plummeted by -344500bps in 2022, and later soared by 633800bps in 2023.
  • Nephros' Operating Margin (Quarter) stood at 26.58% in 2021, then decreased by -2bps to 27.09% in 2022, then rose by 26bps to 19.94% in 2023, then soared by 141bps to 8.19% in 2024, then fell by -20bps to 6.59% in 2025.
  • Its Operating Margin stands at 6.59% for Q3 2025, versus 5.61% for Q2 2025 and 11.61% for Q1 2025.